Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System

被引：0
作者：
Alice Laroni
Giovanni Novi
Nicole Kerlero de Rosbo
Antonio Uccelli
机构：
[1] University of Genoa,Department of Neurosciences Ophthalmology, Genetics, Rehabilitation and Child Health
[2] Advanced Biotechnology Center (ABC),Center of Excellence for Biomedical Research
[3] University of Genoa,Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health
[4] University of Genova,undefined
来源：
Journal of Neuroimmune Pharmacology | 2013年 / 8卷
关键词：
Mesenchymal stem cells; Neurological diseases; Multiple sclerosis; Amyotrophic lateral sclerosis; Alzheimer’s disease; Parkinson’s disease; Multiple system atrophy; Stroke; Brain ischemia; Spinal cord injury;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The diagnosis of a neurological disease of the central nervous system (CNS) is often associated with the anticipation of an irreversible and untreatable disability. This is the case also of multiple sclerosis (MS) where approved treatments effectively modulate the autoimmune attack to myelin antigens, but poorly affect neurodegeneration and do not promote tissue repair. Thus, stem cell-based therapies are increasingly being considered a possible strategy for diseases of the CNS. Mesenchymal stem cells (MSC), the safety of which has been demonstrated in the last 20 years through clinical trials and case studies, are of particular interest in view not only of their neuroprotective, but also of their immunomodulatory properties. Here, we review the therapeutic features of MSC that make them relevant in the treatment of CNS illnesses and discuss the pioneer clinical experience with MSC-based therapy in neurological diseases.
引用
收藏
页码：1062 / 1076
页数：14
相关论文
共 993 条
  • [1] Akiyama Y(2002)Remyelination of the spinal cord following intravenous delivery of bone marrow cells Glia 39 229-236
  • [2] Radtke C(2008)Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat Exp Neurol 211 588-592
  • [3] Honmou O(2012)Transplanted bone marrow mesenchymal stem cells improve memory in rat models of Alzheimer’s disease Stem Cells Int 2012 369417-1203
  • [4] Kocsis JD(2009)Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis Glia 57 1192-1031
  • [5] Andrews EM(2012)Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models Nat Neurosci 377 1019-882
  • [6] Tsai SY(2011)Alzheimer’s disease Lancet 57 874-48
  • [7] Johnson SC(2005)Autologous mesenchymal stem cell transplantation in stroke patients Ann Neurol 30 42-554
  • [8] Farrer JR(2002)Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Exp Hematol 17 547-447
  • [9] Wagner JP(2008)Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols Stem Cells Dev 133 433-104
  • [10] Kopen GC(2010)Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment Brain 1 93-2046
12345678910